iRhythm Technologies Stock (NASDAQ: IRTC)

iRhythm Technologies

IRHYTHM TECHNOLOGIES INC

iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

AAPL

AMZN

IRTC

ISRG

MSFT

PATH



As we close the curtain on 2024, a strange phenomenon is creeping into the market. I’ll call it AI fatigue. There’s a sense that, perhaps, artificial intelligence is a bubble that’s run its course.

Top 3 Robotics and Automation Stocks for the Next AI Boom

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies Inc

Press Releases

General

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

News

Legal

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

Health Care

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Earnings

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

Analyst Ratings

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of  Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Alphatec Holdings

AtriCure

Baxter Intl

Conmed

Enovis

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

Inspire Medical Systems, Inc. Common Stock

Inspire Medical Systems

Integer Holdings Corporation Common Stock

Integer Holdings

Kestra Medical Technologies, Ltd. - Common Stock

Kestra Medical Techs

LeMaitre Vascular

Masimo

NovoCure

Envista Holdings Corporation Common Stock

Envista Holdings

Omnicell

Penumbra

Insulet

PROCEPT BioRobotics Corporation - Common Stock

PROCEPT BioRobotics

QuidelOrtho

Smith & Nephew

Steris

Teleflex

TransMedics Group

Goldman Sachs

Truist Securities

Wells Fargo

Needham

Oppenheimer

Comments

iRhythm Technologies

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga